SCHEMBL30926768

SCHEMBL30926768

Cc1ccccc1NS(=O)(=O)c1cccc(C(=O)Nc2cccc([N+](=O)[O-])c2)c1

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 9/20 0.77
▸ KMT2A Q03164 9/20 0.77
▸ MAPT P10636 6/20 0.77
▸ LMNA P02545 3/20 0.77
▸ ALDH1A1 P00352 3/20 0.77
▸ SMN1; SMN2 Q16637 2/20 0.77
▸ MAPK1 P28482 1/20 0.77
▸ HTT P42858 1/20 0.77
▸ CASP3 P42574 2/20 0.72
▸ SENP8 Q96LD8 2/20 0.72
▸ SENP7 Q9BQF6 2/20 0.72
▸ SENP6 Q9GZR1 2/20 0.72
▸ POLB P06746 2/20 0.60
▸ BLM P54132 1/20 0.60
▸ DDX3X O00571 2/20 0.59
▸ GAA P10253 1/20 0.58
▸ HPGD P15428 1/20 0.58
▸ SIRT2 Q8IXJ6 1/20 0.57
▸ KDM4E B2RXH2 1/20 0.56
▸ TDP1 Q9NUW8 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27181018 1.00 MEN1 (0.77) MEN1KMT2AMAPTLMNAALDH1A1
SCHEMBL30926657 0.87 CASP3 (0.66) MEN1KMT2AMAPTLMNAALDH1A1
SCHEMBL27179660 0.87 CASP3 (0.66) MEN1KMT2AMAPTLMNAALDH1A1
SCHEMBL13532183 0.87 CASP3 (0.85) MEN1KMT2AMAPTLMNAALDH1A1
SCHEMBL30927031 0.87 CASP3 (0.89) MEN1KMT2AMAPTLMNAALDH1A1
SCHEMBL27179429 0.87 CASP3 (0.89) MEN1KMT2AMAPTLMNAALDH1A1
SCHEMBL27179434 0.87 MAPT (1.00) MEN1KMT2AMAPTLMNAALDH1A1
SCHEMBL14484934 0.86 CASP3 (0.87) MEN1KMT2AMAPTLMNAALDH1A1
SCHEMBL30926854 0.85 CASP3 (0.76) MEN1KMT2AMAPTLMNAALDH1A1
SCHEMBL27180605 0.85 CASP3 (0.76) MEN1KMT2AMAPTLMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240099300-A1 SULFONAMIDE APYRASE INHIBITORS TEXAS CROP SCIENCE, INC. 2024-03-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240099300-A1 SULFONAMIDE APYRASE INHIBITORS APEH, ARSA, DNPEP MEN1 4795/4885KMT2A 2544/4885MAPT 4236/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback